LTRN: Lantern Pharma Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Lantern Pharma Inc (LTRN).
$34.40M Market Cap.
LTRN Market Cap. (MRY)
LTRN Shares Outstanding (MRY)
LTRN Assets (MRY)
Total Assets
$25.57M
Total Liabilities
$4.38M
Total Investments
$16.50M
LTRN Income (MRY)
Revenue
$0
Net Income
-$20.78M
Operating Expense
$22.22M
LTRN Cash Flow (MRY)
CF Operations
-$17.81M
CF Investing
$3.37M
CF Financing
$66.71K
LTRN Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $25,571,792 (-41.41%) | $43,647,616 (-25.82%) | $58,836,321 (-20.44%) | $73,950,477 (263.22%) |
Assets Current | $25,247,629 (-41.75%) | $43,341,325 (-26.19%) | $58,722,737 (-19.24%) | $72,716,400 (259.33%) |
Assets Non-Current | $324,163 (5.83%) | $306,291 (169.66%) | $113,584 (-90.80%) | $1,234,077 (905.67%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $21,187,774 (-48.21%) | $40,907,934 (-27.00%) | $56,038,024 (-21.70%) | $71,571,420 (263.33%) |
Property Plant & Equipment Net | $287,425 (2.50%) | $280,422 (193.04%) | $95,695 (-55.74%) | $216,188 (905.20%) |
Cash & Equivalents | $7,511,079 (-65.76%) | $21,937,749 (-41.88%) | $37,742,966 (-28.14%) | $52,524,295 (173.15%) |
Accumulated Other Comprehensive Income | $153,990 (243.30%) | -$107,460 (71.07%) | -$371,386 (-300.68%) | -$92,689 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $16,501,984 (-14.78%) | $19,364,923 (7.62%) | $17,994,299 (-6.29%) | $19,201,152 (0%) |
Investments Current | $16,501,984 (-14.78%) | $19,364,923 (7.62%) | $17,994,299 (-6.29%) | $19,201,152 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,140,361 (65.27%) | $2,505,211 (-8.75%) | $2,745,407 (26.28%) | $2,174,109 (293.62%) |
Accumulated Retained Earnings (Deficit) | -$76,025,617 (-37.62%) | -$55,244,404 (-40.63%) | -$39,282,870 (-56.99%) | -$25,022,924 (-97.66%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $243,657 (3.92%) | $234,471 (343.32%) | $52,890 (-74.19%) | $204,948 (88.89%) |
Debt Current | $190,814 (10.31%) | $172,975 (227.05%) | $52,890 (-65.22%) | $152,058 (0%) |
Debt Non-Current | $52,843 (-14.07%) | $61,496 (0%) | $0 (0%) | $52,890 (-51.25%) |
Total Liabilities | $4,384,018 (60.02%) | $2,739,682 (-2.09%) | $2,798,297 (17.62%) | $2,379,057 (260.01%) |
Liabilities Current | $4,331,175 (61.72%) | $2,678,186 (-4.29%) | $2,798,297 (20.30%) | $2,326,167 (321.15%) |
Liabilities Non-Current | $52,843 (-14.07%) | $61,496 (0%) | $0 (0%) | $52,890 (-51.25%) |
LTRN Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $6,090,747 (1.80%) | $5,983,255 (2.63%) | $5,829,799 (16.11%) | $5,020,928 (37.00%) |
Research & Development Expense | $16,125,690 (35.57%) | $11,894,315 (38.26%) | $8,602,954 (13.64%) | $7,570,580 (237.49%) |
Operating Expenses | $22,216,437 (24.27%) | $17,877,570 (23.87%) | $14,432,753 (14.62%) | $12,591,508 (113.12%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$20,781,213 (-30.20%) | -$15,961,534 (-11.93%) | -$14,259,946 (-15.34%) | -$12,363,029 (-109.25%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$20,781,213 (-30.20%) | -$15,961,534 (-11.93%) | -$14,259,946 (-15.34%) | -$12,363,029 (-109.25%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$20,781,213 (-30.20%) | -$15,961,534 (-11.93%) | -$14,259,946 (-15.34%) | -$12,363,029 (-109.25%) |
Weighted Average Shares | $10,762,319 (-0.74%) | $10,842,365 (-0.08%) | $10,850,579 (-0.50%) | $10,904,927 (153.31%) |
Weighted Average Shares Diluted | $10,762,319 (-0.74%) | $10,842,365 (-0.08%) | $10,850,579 (-0.50%) | $10,904,927 (153.31%) |
Earning Before Interest & Taxes (EBIT) | -$20,781,213 (-30.20%) | -$15,961,534 (-11.93%) | -$14,259,946 (-15.34%) | -$12,363,029 (-109.25%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$22,216,437 (-24.27%) | -$17,877,570 (-23.87%) | -$14,432,753 (-14.62%) | -$12,591,508 (-113.12%) |
LTRN Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $3,369,368 (462.22%) | -$930,210 (-618.89%) | $179,268 (100.92%) | -$19,530,586 (-120929.84%) |
Net Cash Flow from Financing | $66,710 (113.34%) | -$499,997 (77.09%) | -$2,182,498 (-103.44%) | $63,416,122 (167.97%) |
Net Cash Flow from Operations | -$17,813,201 (-24.16%) | -$14,346,548 (-12.37%) | -$12,767,492 (-20.54%) | -$10,591,543 (-87.41%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$14,426,670 (8.72%) | -$15,805,217 (-6.93%) | -$14,781,329 (-144.39%) | $33,295,063 (85.00%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $3,381,963 (471.04%) | -$911,476 (-540.09%) | $207,112 (101.06%) | -$19,515,087 (0%) |
Capital Expenditure | -$12,595 (32.77%) | -$18,734 (32.72%) | -$27,844 (-79.65%) | -$15,499 (3.95%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $66,710 (113.34%) | -$499,997 (79.86%) | -$2,482,286 (-103.65%) | $68,060,328 (159.28%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$49,547 (-74.08%) | -$28,462 (-168.33%) | -$10,607 (-1091.31%) | $1,070 (0%) |
Share Based Compensation | $732,893 (-31.35%) | $1,067,515 (-10.12%) | $1,187,745 (23.52%) | $961,545 (-19.35%) |
Depreciation Amortization & Accretion | $190,493 (8.95%) | $174,843 (13.03%) | $154,681 (58.78%) | $97,421 (2775.47%) |
LTRN Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -72.60% (-112.90%) | -34.10% (-44.49%) | -23.60% (-47.50%) | -16.00% (55.92%) |
Return on Average Assets (ROAA) | -63.40% (-96.89%) | -32.20% (-44.39%) | -22.30% (-42.95%) | -15.60% (54.12%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -121.00% (-50.12%) | -80.60% (-3.60%) | -77.80% (7.27%) | -83.90% (95.12%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -1.65 (43.23%) | -2.91 (36.85%) | -4.61 (34.71%) | -7.06 (49.74%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.62 (42.83%) | 1.14 (-2.82%) | 1.17 (-6.17%) | 1.25 (-79.48%) |
Debt to Equity Ratio (D/E) | 0.21 (208.96%) | 0.07 (34.00%) | 0.05 (51.52%) | 0.03 (-2.94%) |
Earnings Per Share (EPS) | -1.93 (-31.29%) | -1.47 (-12.21%) | -1.31 (-15.93%) | -1.13 (17.52%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.66 (-24.98%) | -1.32 (-12.38%) | -1.18 (-21.17%) | -0.97 (26.12%) |
Book Value Per Share (BVPS) | 1.97 (-47.81%) | 3.77 (-26.95%) | 5.17 (-21.30%) | 6.56 (43.42%) |
Tangible Assets Book Value Per Share (TABVPS) | 2.38 (-40.98%) | 4.03 (-25.75%) | 5.42 (-20.04%) | 6.78 (43.39%) |
Enterprise Value Over EBIT (EV/EBIT) | -1 (0.00%) | -1 (50.00%) | -2 (33.33%) | -3 (82.35%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.29 (3.94%) | -1.34 (26.72%) | -1.83 (33.55%) | -2.76 (83.54%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 5.83 (-63.98%) | 16.18 (-22.88%) | 20.98 (-32.87%) | 31.26 (-14.68%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$17,825,796 (-24.09%) | -$14,365,282 (-12.27%) | -$12,795,336 (-20.63%) | -$10,607,042 (-87.15%) |
Enterprise Value (EV) | $26,591,698 (25.30%) | $21,222,292 (-17.96%) | $25,869,478 (-23.58%) | $33,850,656 (-65.81%) |
Earnings Before Tax (EBT) | -$20,781,213 (-30.20%) | -$15,961,534 (-11.93%) | -$14,259,946 (-15.34%) | -$12,363,029 (-109.25%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$20,590,720 (-30.43%) | -$15,786,691 (-11.92%) | -$14,105,265 (-15.00%) | -$12,265,608 (-107.72%) |
Invested Capital | $13,973,195 (-27.47%) | $19,266,152 (5.00%) | $18,347,948 (-4.96%) | $19,304,963 (2711.83%) |
Working Capital | $20,916,454 (-48.56%) | $40,663,139 (-27.29%) | $55,924,440 (-20.55%) | $70,390,233 (257.59%) |
Tangible Asset Value | $25,571,792 (-41.41%) | $43,647,616 (-25.82%) | $58,836,321 (-20.44%) | $73,950,477 (263.22%) |
Market Capitalization | $34,403,273 (-26.05%) | $46,519,491 (-29.06%) | $65,576,522 (-26.55%) | $89,278,692 (-25.41%) |
Average Equity | $28,620,662 (-38.83%) | $46,788,610 (-22.49%) | $60,363,572 (-21.77%) | $77,161,221 (374.60%) |
Average Assets | $32,796,552 (-33.86%) | $49,588,616 (-22.45%) | $63,945,754 (-19.18%) | $79,123,352 (355.36%) |
Invested Capital Average | $17,174,618 (-13.26%) | $19,800,774 (8.09%) | $18,318,188 (24.32%) | $14,734,720 (4184.10%) |
Shares | 10,784,725 (-0.78%) | 10,869,040 (0.11%) | 10,857,040 (-2.96%) | 11,187,806 (79.94%) |
